STOCK TITAN
  1. Home
  2. Sec-filings
  3. RMTI
  4. [Form 4] ROCKWELL MEDICAL, INC. Insider Trading Activity

Director Joan Lau receives 9,633-share award at ROCKWELL MEDICAL (RMTI)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lau Joan reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. director Joan Lau received a grant of 9,633 shares of Common Stock as a stock award, with no cash paid per share. These restricted stock units vest on July 1, 2027, subject to her continued service through the 2027 Annual Meeting. A 1-for-10 reverse split effective July 1, 2026 adjusted her holdings to 20,944 shares after the reported grant.

Positive

  • None.

Negative

  • None.
Insider Lau Joan
Role null
Type Security Shares Price Value
Grant/Award Common Stock 9,633 $0.00 --
Holdings After Transaction: Common Stock — 20,944 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Stock award 9,633 shares Grant of Common Stock to director on July 1, 2026
Grant price $0.0000 per share Equity compensation, no cash paid for award shares
Post-transaction holdings 20,944 shares Shares beneficially owned following reported transaction
Reverse split ratio 1-for-10 Reverse split effective July 1, 2026
Vesting date July 1, 2027 Restricted stock units vest subject to continued service
Restricted stock units financial
"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
Amount of Securities Beneficially Owned Following Reported Transaction(s) financial
"the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4"
equity awards financial
"proportionate adjustments were made to the Issuer's outstanding equity awards"
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lau Joan
(Last)(First)(Middle)
30142 WIXOM ROAD
(Street)
WIXOM MICHIGAN 48393
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)9,633A$020,944(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-Fact for Joan Lau07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Joan Lau report for ROCKWELL MEDICAL (RMTI)?

Joan Lau reported receiving a grant of 9,633 shares of ROCKWELL MEDICAL Common Stock as a stock award at no cash cost. This is an equity compensation grant, not an open-market share purchase or sale.

When do Joan Lau’s new ROCKWELL MEDICAL (RMTI) restricted stock units vest?

The 9,633 restricted stock units vest on July 1, 2027, if Joan Lau continues serving the company through the 2027 Annual Meeting. Vesting ties the award to ongoing board service over this multi-year period.

How many ROCKWELL MEDICAL (RMTI) shares does Joan Lau hold after this Form 4?

After the reported stock award and the share adjustment for the reverse split, Joan Lau beneficially owns 20,944 shares of ROCKWELL MEDICAL Common Stock directly. This figure reflects the 1-for-10 reverse stock split.

What reverse stock split did ROCKWELL MEDICAL (RMTI) implement on July 1, 2026?

Effective at 12:01 AM on July 1, 2026, ROCKWELL MEDICAL implemented a 1-for-10 reverse split of its Common Stock. This reduced the number of shares outstanding and proportionally adjusted existing equity awards, including those held by Joan Lau.

Did Joan Lau buy or sell ROCKWELL MEDICAL (RMTI) shares in the market?

No market buy or sell occurred. The Form 4 shows an acquisition coded as a grant or award, with a price of $0.0000 per share, indicating compensation rather than an open-market transaction.